OnKure Therapeutics Statistics
Total Valuation
OKUR has a market cap or net worth of $26.21 million. The enterprise value is -$69.49 million.
| Market Cap | 26.21M |
| Enterprise Value | -69.49M |
Important Dates
The last earnings date was Tuesday, May 6, 2025, before market open.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OKUR has 13.44 million shares outstanding. The number of shares has decreased by -49.42% in one year.
| Current Share Class | 12.76M |
| Shares Outstanding | 13.44M |
| Shares Change (YoY) | -49.42% |
| Shares Change (QoQ) | +5.09% |
| Owned by Insiders (%) | 17.20% |
| Owned by Institutions (%) | 47.57% |
| Float | 4.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.29 |
| P/TBV Ratio | 0.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.17, with a Debt / Equity ratio of 0.01.
| Current Ratio | 11.17 |
| Quick Ratio | 11.00 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -410.19 |
Financial Efficiency
Return on equity (ROE) is -108.16% and return on invested capital (ROIC) is -68.49%.
| Return on Equity (ROE) | -108.16% |
| Return on Assets (ROA) | -61.00% |
| Return on Invested Capital (ROIC) | -68.49% |
| Return on Capital Employed (ROCE) | -66.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.28M |
| Employee Count | 46 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 3.66 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 15.23 |
| Average Volume (20 Days) | 80,868 |
Short Selling Information
The latest short interest is 574,041, so 4.27% of the outstanding shares have been sold short.
| Short Interest | 574,041 |
| Short Previous Month | 1.15M |
| Short % of Shares Out | 4.27% |
| Short % of Float | 13.46% |
| Short Ratio (days to cover) | 10.28 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -60.71M |
| Pretax Income | n/a |
| Net Income | -59.06M |
| EBITDA | -60.25M |
| EBIT | -60.71M |
| Earnings Per Share (EPS) | -$8.78 |
Balance Sheet
The company has $96.66 million in cash and $955,000 in debt, giving a net cash position of $95.71 million or $7.12 per share.
| Cash & Cash Equivalents | 96.66M |
| Total Debt | 955,000 |
| Net Cash | 95.71M |
| Net Cash Per Share | $7.12 |
| Equity (Book Value) | 90.65M |
| Book Value Per Share | 6.74 |
| Working Capital | 89.39M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OKUR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 49.42% |
| Shareholder Yield | 49.42% |
| Earnings Yield | -225.33% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for OKUR is $32.25, which is 1,553.85% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.25 |
| Price Target Difference | 1,553.85% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |